Effect of vehicles on release of meloxicam from various topical formulations

Open Drug Delivery Journal

Volumn 3, Issue , 2009, Pages 19-23

  Yener, Gülgün ^a   Dal, Özlem ^a   Üner, Melike ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Assay validation; Drug release; Meloxicam; Multiple emulsion; Poorly water soluble drug

Indexed keywords

CARBOPOL 934; CELLULOSE ACETATE; DRUG VEHICLE; MELOXICAM; WATER OIL CREAM;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; HYDROGEL; LIPOPHILICITY; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY; VISCOSITY;

EID: 77951023624     PISSN: None     EISSN: 18741266     Source Type: Journal    
DOI: 10.2174/1874126600903010019     Document Type: Article

References (19)

1. Baboota, S.; Agarwal, S.P. Meloxicam complexation with betacyclodextrin: influence on the anti-inflammatory and ulcerogenic activity. Pharmazie, 2003, 58, 73-74. (Pubitemid 36157973)
2. Lanas, A.; Sopeña, F. Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications. Gastroenterol. Clin. North Am., 2009, 38, 333-352.
3. WHO Drug Information, Anonymous. WHO Drug Information. In Meloxicam safety similar to other NSAID's; World Helath Organization: Geneva, 1998, Vol. 12, p. 147.
4. Cordero, J.A.; Alarcon, E.; Escribano, R.; Obach, J.; Domenech, A. A comparative study of the transdermal penetration of a series of NSAIDs. J. Pharm. Sci., 1997, 86, 503-508.
5. Gwak, H.S.; Chun, I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm., 2002, 236, 57-64. (Pubitemid 34219373)
6. Yener, G.; Gönüllü, Ü.; Üner, M.; Deǧim, T.; Araman, A. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin. Pharmazie, 2003, 58, 330-333. (Pubitemid 36604910)
7. O'Hanlon, J.J.; Mc Cleane, G.; Muldoon, T. Preoperative application of piroxicam gel compared to a local anaesthetic field block for postoperative analgesia. Acta Anaesthesiol. Scand., 1996, 40, 715-718. (Pubitemid 26232678)
8. Wilgus, T.A.; Ross, M.S.; Parrett, M.L.; Oberyszy, T.M. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins Other Lipid Mediat., 2000, 62, 367-370. (Pubitemid 30782689)
9. th ed. Taylor and Francis Group: USA, 2005, pp. 473-480.
10. Mura, P.; Faucci, M.T.; Bramanti, G.; Corti, P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur. J. Pharm. Sci., 2000, 9, 365-372. (Pubitemid 30069527)
11. Mura, P.; Nassini, C.; Proietti, D.; Manderioli, A.; Corti, P. Influence of vehicle composition variations on the in vitro and ex vivo clonazepam diffusion from hydrophilic ointment bases. Pharm. Acta Helv., 1996, 71, 147-154. (Pubitemid 26281325)
12. Loftsson, T.; Konrádsdóttir, F.; Másson, M. Development and evaluation of an artificial membrane for determination of drug availability. Int. J. Pharm., 2006, 326, 60-68. (Pubitemid 44647747)
13. Dal, Ö. Meloksikam içeren topikal formülasyonlar üzerine araştirmalar; M.Sc. Thesis, Istanbul University: Turkey 2004.
14. Tatar Ulu, S. A new spectrophotometric method for the determination of finasteride tablets. Spectrochim. Acta Part A, 2007, 67, 778-783. (Pubitemid 46809655)
15. Vijaya Kumar, S.G.; Mishra, D.N. Preparation and evaluation of solid dispersion of meloxicam with skimmed milk. Yakugaku Zasshi, 2006, 126, 93-97. (Pubitemid 43171740)
16. Hung, C.-F.; Fang, C.-L.; Liao, M.-H.; Fang, J.-Y. The effect of oil components on the physicochemical properties and drug delivery of emulsions: Tocol emulsion versus lipid emulsion. Int. J. Pharm., 2007, 335, 193-202. (Pubitemid 46505069)
17. Jantharaprapap, R.; Stagni, G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int. J. Pharm., 2007, 343, 26-33. (Pubitemid 47321008)
18. Chang, J.-S.; Huang, Y.-B.; Hou, S.-S.; Wang, R.-J., Wu, P.-C.; Tsai, Y.-H. Formulation optimization of meloxicam sodium gel using response surface methodology. Int. J. Pharm., 2007, 338, 48-54. (Pubitemid 46777218)
19. th ed., Lea and Febiger: USA, 1993.